- Daratumumab becomes the First FDA-approved treatment for patients with newly diagnosed light chain (AL) amyloidosis January 17, 2021
- Watch the webinar on ASH 2020 myeloma and AL amyloidosis highlights December 18, 2020
- ASH 2020 AL amyloidosis highlights December 17, 2020
- ASH 2020 myeloma highlights December 10, 2020
- ASH 2020 | Data on Real World Evidence (RWE) on AL amyloidosis December 10, 2020